• Go global

    For successful clinical trials today, it’s necessary to go global.  But challenges still abound

  • Thumbnail

    September issue out now!

    Feat. The challenges of global clinical trials; Trump takes on big pharma; the best UK pharma tweeters

  • SmartPeople: Lisa Anson

    The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the coming years, and how the UK can help smaller companies like Redx to thrive

  • The best pharma tweeters 
in the UK

    A new report looks at the effectiveness of dedicated UK twitter accounts for pharma companies

News

View all
Thumbnail image for EU approves new option for metastatic melanoma

EU approves new option for metastatic melanoma

The European Commission (EC) has granted marketing authorisation for Pierre Fabre’s Braftovi and Mektovi combination therapy for the treatment of adults with unresectable or metastatic melanoma with a BRAFV600 mutation.

24th September 2018

Thumbnail image for CHMP puts 13 therapies forward for EU approval

CHMP puts 13 therapies forward for EU approval

Marking a bumper month for Committee for Medicinal Products for Human Use (CHMP) decisions, 13 medicines have been put forward for approval in the region, including three orphan medicines.

24th September 2018

Thumbnail image for Medical & Scientific Excellence Awards - Have you entered yet?

Medical & Scientific Excellence Awards - Have you entered yet?

New from PharmaTimes Media is the Medical & Scientific Excellence Awards.Highlighting this important area of work within the pharmaceutical industry, the awards are designed to recognise the outstanding achievements of medical and scientific professionals.

21st September 2018

Web Exclusives

View all
Thumbnail image for Connecting care

Connecting care

A fully digital NHS should be close to reality, but it’s a challenge that many hospitals are not ready to take on

Thumbnail image for SmartPeople: Kris Sterkens

SmartPeople: Kris Sterkens

The industry vet and current company group chairman of Janssen EMEA gives his views on the past, present and future of the pharma industry

Thumbnail image for Company focus: Adaptimmune

Company focus: Adaptimmune

Despite the excitement surrounding T-cell therapy, CAR-T cells have fallen short in effectiveness against solid tumours. Oxfordshire-based Adaptimmune is one of the companies exploring T-cell receptors as a promising alternative. We spoke to the company’s chief technology officer Gwen Binder-Scholl about the science behind this challenging but exciting therapeutic area

Thumbnail image for Go global

Go global

For successful clinical trials today, it’s necessary to go global.  But challenges still abound

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download